Expertini Wire Wire
  • Expertini Wire profile
    • Browse the Wire

    "fda" โ€” Press Releases

    8,207 releases found

    Active filters: ๐Ÿ” fda ร— Clear all ร—
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD). GREENWOOD VILLAGE, Colo. & LOS ANGELES, CO-ANANDA-SCIENTIFIC
    Publisher  ยท  2022
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Best's Commentary: Brand Profile and Pricing Models in Focus as UK Insurers Adjust to New FCA Rules. LONDON, AM-BEST
    Publisher  ยท  2022
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer
    Publisher  ยท  2022
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
    Publisher  ยท  2022
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    A LEO Pharma bejelentette, hogy a kรถzรฉpsรบlyos-sรบlyos atรณpiรกs dermatitiszben szenvedล‘ felnล‘ttek kezelรฉsรฉre szolgรกlรณ, specifikusan az IL-13-at cรฉlzรณ Adbryโ„ข (tralokinumab) elsล‘ รฉs ez idรกig egyetlen ilyen kรฉszรญtmรฉnykรฉnt megkapta az FDA jรณvรกhagyรกsรกt. BALLERUP, Dรกnia, LEO-PHARMA
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    LEO Pharma anuncia a aprovaรงรฃo pelo FDA do Adbryโ„ข (tralocinumab) como o primeiro e รบnico tratamento direcionado especificamente ร  IL-13 para adultos com dermatite atรณpica moderada a grave. BALLERUP, Dinamarca, LEO-PHARMA
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    LEO Pharma annuncia l'approvazione per Adbryโ„ข (tralokinumab) da parte della FDA, come primo e unico trattamento mirato specificamente all'IL-13 per gli adulti con dermatite atopica da moderata a grave. BALLERUP, Danimarca, LEO-PHARMA
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    LEO Pharma anuncia que la FDA ha aprobado Adbryโ„ข (tralokinumab) como el primer y รบnico tratamiento dirigido especรญficamente a la IL-13 para adultos con dermatitis atรณpica de moderada a grave. BALLERUP, Dinamarca, LEO-PHARMA
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    LEO Pharma Announces FDA Approval of Adbryโ„ข (tralokinumab) as the First and Only Treatment Specifically Targeting IL-13 for Adults With Moderate-to-Severe Atopic Dermatitis. BALLERUP, Denmark, LEO-PHARMA
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Aimmuneโ€™s PALFORZIAยฎโ–ผ [defatted powder of Arachis hypogaea L., semen (peanuts)] Receives Final Appraisal Determination (FAD) as Positive Draft Guidance From NICE for the Treatment of Peanut Allergy in Patients Aged 4 to 17 Years. LONDON, AIMMUNE-THERAPEUTICS-UK
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Takeda Recebe Carta de Resposta Completa do FDA dos EUA para TAK-721. OSAKA, Japรฃo & CAMBRIDGE, Mass., MA-TAKEDA-PHARMACEUTICAL
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Takeda Receives Complete Response Letter from the U.S. FDA for TAK-721. OSAKA, Japan & CAMBRIDGE, Mass., MA-TAKEDA-PHARMACEUTICAL
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Caldera Medical Announces FDA Clearance for New Desaraยฎ TVez for Stress Urinary Incontinence. LOS ANGELES, CA-CALDERA-MEDICAL
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Emera Technologies Receives UL 9540 Fire Safety Certification for BlockEnergyTM Microgrid Platformโ€™s Energy Storage and Control System. TAMPA, Fla., FL-EMERA-TECHNOLOGIES
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Health ๐Ÿ“ฃ PR News
    VBI Vaccines Announces FDA Approval of PreHevbrioโ„ข for the Prevention of Hepatitis B in Adults. CAMBRIDGE, Mass., MA-VBI-VACCINES
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    Forrester posiziona Appian fra i leader nella Digital Process Automation
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention. LONDON, VIIV-HEALTHCARE
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Health ๐Ÿ“ฃ PR News
    FDA APPROVES OTEZLAยฎ (APREMILAST) FOR THE TREATMENT OF ADULT PATIENTS WITH PLAQUE PSORIASIS, REGARDLESS OF SEVERITY LEVEL
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    ๐Ÿ“‹ Business ๐Ÿ“ฃ PR News
    RegeneRx Joint Venture Will Hold Pre-BLA Meeting with FDA on February 28, 2022
    Publisher  ยท  2021
    Read Release โ†’ ๐Ÿ“‹ Pickups
    โ€น 1 โ€ฆ 406 407 408 409 410 411 โ€บ
    ๐Ÿ“ฃ
    Distribute Your Release
    Reach 1.25M+ monthly readers. Free to start, $15 for full distribution.
    Submit a Release

    By Industry

    ๐ŸŽฏ Recruitment & Hiring 0 ๐Ÿ‘ฅ Human Resources 0 ๐Ÿค– Artificial Intelligence 0 โš™๏ธ HR Technology 0 ๐Ÿข Workplace & Culture 0 ๐ŸŒ Diversity & Inclusion 0 ๐Ÿ”ฎ Future of Work 0 ๐Ÿ’ฐ Compensation & Benefits 0 ๐Ÿ“š Learning & Development 0 โญ Talent Management 0 ๐Ÿ“Š Labour Market & Economics 0 ๐Ÿ† Executive Appointments 0 ๐Ÿค Mergers & Acquisitions 0 ๐Ÿš€ Product Launches 0 ๐Ÿ“‘ Research & Reports 0 ๐ŸŽค Events & Conferences 0 ๐Ÿฅ‡ Awards & Recognition 0 ๐Ÿ”— Partnerships & Integrations 0 ๐Ÿ“ฐ Company News 0 ๐Ÿ“‹ Other 0

    By Release Type

    ๐Ÿ“ฃ Press Release 150 ๐Ÿ“ข Announcement 0 ๐Ÿš€ Product Launch 0 ๐Ÿ“Š Report 0 ๐ŸŽค Event 0 ๐Ÿ” Case Study 0 ๐Ÿ“‘ White Paper 0 ๐ŸŽ™๏ธ Interview 0 ๐Ÿ’ฌ Opinion 0
    ๐Ÿ””
    Article Alerts
    Get notified when new releases match your keywords or category.
    Set Up Alerts